Your browser doesn't support javascript.
loading
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC.
Lai, Gillianne G Y; Yeo, Jia Chi; Jain, Amit; Zhou, Siqin; Pang, Mengyuan; Alvarez, Jacob J S; Sim, Ngak Leng; Tan, Aaron C; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie P L; Rohatgi, Neha; Yeong, Joe P S; Takano, Angela; Lim, Kiat Hon; Gogna, Apoorva; Too, Chow Wei; Da Zhuang, Kun; Tan, Wan Ling; Kanesvaran, Ravindran; Ng, Quan Sing; Ang, Mei Kim; Rajasekaran, Tanujaa; Wang, Lanying; Toh, Chee Keong; Lim, Wan-Teck; Tam, Wai Leong; Tan, Sze Huey; Skanderup, Anders M J; Tan, Eng-Huat; Tan, Daniel S W.
Afiliação
  • Lai GGY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Yeo JC; Genome Institute of Singapore, Singapore.
  • Jain A; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Zhou S; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Pang M; Genome Institute of Singapore, Singapore.
  • Alvarez JJS; Genome Institute of Singapore, Singapore.
  • Sim NL; Genome Institute of Singapore, Singapore.
  • Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Suteja L; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore.
  • Lim TW; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Guo YA; Genome Institute of Singapore, Singapore.
  • Shen M; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Saw SPL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Rohatgi N; Genome Institute of Singapore, Singapore.
  • Yeong JPS; Institute of Molecular and Cell Biology, Singapore.
  • Takano A; Division of Pathology, Singapore General Hospital, Singapore.
  • Lim KH; Division of Pathology, Singapore General Hospital, Singapore.
  • Gogna A; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.
  • Too CW; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.
  • Da Zhuang K; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.
  • Tan WL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Ng QS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Ang MK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Rajasekaran T; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Wang L; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Toh CK; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Lim WT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Tam WL; Genome Institute of Singapore, Singapore.
  • Tan SH; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Skanderup AMJ; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Tan EH; Genome Institute of Singapore, Singapore.
  • Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
JTO Clin Res Rep ; 3(12): 100416, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36426287
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura